Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAH-box polypeptide 29 pseudogene" (ENSG00000230987, LOC647132) refers to a *pseudogene*, which is a non-functional copy of a protein-coding gene—in this case, of the **DEAH-box helicase 29 (DHX29)** gene. Pseudogenes do not encode functional proteins, and by definition, lack the molecular function and druggability inherent to bona fide therapeutic targets[3]. The functional DHX29 gene product is an RNA helicase involved in translation initiation and possibly cancer cell proliferation, but the pseudogene neither encodes this protein nor assumes those biological roles[1][3]. Pseudogenes, while potentially involved in gene regulation or as disease biomarkers, are generally not considered therapeutic targets unless there is clear evidence to the contrary, which is lacking in this case[3][5]. Notes: - The term "pseudogene" indicates that ENSG00000230987 is distinguished from the functional DHX29 gene (ENSG00000067248), and does not itself encode a functional helicase or any protein[3]. - There is nothing to suggest this pseudogene is a therapeutic target, nor are there drugs or mechanisms of action relevant to it. - If the goal is to target the *functional* helicase (DHX29), information should reference the protein-coding gene, not its pseudogene[1]. Critical clarification: This target is a *pseudogene*, not a receptor, enzyme, transporter, or any canonical therapeutic target[3]. It is not actionable in the conventional sense used in drug discovery or biomedical therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAH box polypeptide 29 pseudogene.